294 related articles for article (PubMed ID: 25662495)
1. Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.
Sonnenberg SB; Rane AA; Liu CJ; Rao N; Agmon G; Suarez S; Wang R; Munoz A; Bajaj V; Zhang S; Braden R; Schup-Magoffin PJ; Kwan OL; DeMaria AN; Cochran JR; Christman KL
Biomaterials; 2015 Mar; 45():56-63. PubMed ID: 25662495
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
Wang Y; Ahmad N; Wani MA; Ashraf M
J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction.
Makarevich PI; Dergilev KV; Tsokolaeva ZI; Boldyreva MA; Shevchenko EK; Gluhanyuk EV; Gallinger JO; Menshikov MY; Parfyonova YV
PLoS One; 2018; 13(5):e0197566. PubMed ID: 29787588
[TBL] [Abstract][Full Text] [Related]
4. Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.
Singelyn JM; Sundaramurthy P; Johnson TD; Schup-Magoffin PJ; Hu DP; Faulk DM; Wang J; Mayle KM; Bartels K; Salvatore M; Kinsey AM; Demaria AN; Dib N; Christman KL
J Am Coll Cardiol; 2012 Feb; 59(8):751-63. PubMed ID: 22340268
[TBL] [Abstract][Full Text] [Related]
5. Decellularized heart ECM hydrogel using supercritical carbon dioxide for improved angiogenesis.
Seo Y; Jung Y; Kim SH
Acta Biomater; 2018 Feb; 67():270-281. PubMed ID: 29223704
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.
Gallo S; Sala V; Gatti S; Crepaldi T
Clin Sci (Lond); 2015 Dec; 129(12):1173-93. PubMed ID: 26561593
[TBL] [Abstract][Full Text] [Related]
7. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
Anderson CD; Heydarkhan-Hagvall S; Schenke-Layland K; Yang JQ; Jordan MC; Kim JK; Brown DA; Zuk PA; Laks H; Roos KP; Maclellan WR; Beygui RE
J Surg Res; 2008 Aug; 148(2):164-71. PubMed ID: 18067924
[TBL] [Abstract][Full Text] [Related]
8. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.
Seif-Naraghi SB; Horn D; Schup-Magoffin PJ; Christman KL
Acta Biomater; 2012 Oct; 8(10):3695-703. PubMed ID: 22750737
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
[TBL] [Abstract][Full Text] [Related]
10. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.
Salimath AS; Phelps EA; Boopathy AV; Che PL; Brown M; García AJ; Davis ME
PLoS One; 2012; 7(11):e50980. PubMed ID: 23226440
[TBL] [Abstract][Full Text] [Related]
11. An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal "Myocardial Repair: PRP, Hydrogel and Supplements".
Vu TD; Pal SN; Ti LK; Martinez EC; Rufaihah AJ; Ling LH; Lee CN; Richards AM; Kofidis T
Biomaterials; 2015 Mar; 45():27-35. PubMed ID: 25662492
[TBL] [Abstract][Full Text] [Related]
12. A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model.
Zhang Y; Zhu D; Wei Y; Wu Y; Cui W; Liuqin L; Fan G; Yang Q; Wang Z; Xu Z; Kong D; Zeng L; Zhao Q
Acta Biomater; 2019 Mar; 86():223-234. PubMed ID: 30660010
[TBL] [Abstract][Full Text] [Related]
13. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.
Koudstaal S; Bastings MM; Feyen DA; Waring CD; van Slochteren FJ; Dankers PY; Torella D; Sluijter JP; Nadal-Ginard B; Doevendans PA; Ellison GM; Chamuleau SA
J Cardiovasc Transl Res; 2014 Mar; 7(2):232-41. PubMed ID: 24395494
[TBL] [Abstract][Full Text] [Related]
14. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
15. A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.
Steele AN; Cai L; Truong VN; Edwards BB; Goldstone AB; Eskandari A; Mitchell AC; Marquardt LM; Foster AA; Cochran JR; Heilshorn SC; Woo YJ
Biotechnol Bioeng; 2017 Oct; 114(10):2379-2389. PubMed ID: 28574594
[TBL] [Abstract][Full Text] [Related]
16. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
17. Necroptosis Induced by Ad-HGF Activates Endogenous C-Kit+ Cardiac Stem Cells and Promotes Cardiomyocyte Proliferation and Angiogenesis in the Infarcted Aged Heart.
Liu J; Wu P; Wang H; Wang Y; Du Y; Cheng W; Xu Z; Zhou N; Wang L; Yang Z
Cell Physiol Biochem; 2016; 40(5):847-860. PubMed ID: 27941320
[TBL] [Abstract][Full Text] [Related]
18. Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.
Yoshizumi T; Zhu Y; Jiang H; D'Amore A; Sakaguchi H; Tchao J; Tobita K; Wagner WR
Biomaterials; 2016 Mar; 83():182-93. PubMed ID: 26774561
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.
Jin H; Wyss JM; Yang R; Schwall R
Curr Pharm Des; 2004; 10(20):2525-33. PubMed ID: 15320761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
